G-CSF Receptor (Granulocyte Colony-stimulating Factor Receptor, G-CSF-R, CD114, Csf3r, Csfgr)
Product Sizes
500ug
£1042.00
G8950-50P-500UG
About this Product
- SKU:
- G8950-50P
- translate.label.attr.clone:
- 680206
- Clonality:
- Monoclonal
- Extra Details:
- Granulocyte colony stimulating factor is a pleiotropic cytokine best known for its specific effects on the proliferation, differentiation, and activation of hematopoietic cells of the neutrophilic and granulocyte lineage. G-CSF plays an important role in defense against infection, in inflammation and repair, and in the maintenance of steady state hematopoiesis. Cell activation by G-CSF is mediated by granulocyte colony stimulating factor receptor alpha (G-CSF R; also CD114), a 95-105kD type I transmembrane protein and member of the cytokine receptor superfamily, type I cytokine receptor family, and type 2 subfamily of receptor proteins. Mouse G-CSF R is synthesized as an 837aa precursor that contains a 25aa signal sequence, a 601aa extracellular domain a 24aa transmembrane region, and a 187aa cytoplasmic tail. The ECD contains one Ig-like C2-type domain, five fibronectin type-III domains, and 11 potential sites for N-linked glycosylation. Within the ECD there is also a WSXWS motif aa319-323 that is necessary for proper protein folding and thereby efficient intracellular transport and cell-surface receptor binding. Also, within the cytoplasmic domain there is a Box 1 motif which is required for JAK interaction and/or activation. Mouse G-CSF R shares 63% aa sequence identity with human G-CSF R. G-CSF R is expressed in mature neutrophils, neutrophilic precursors, myeloid leukemia cells, and placenta. Mutations have been found in the gene encoding G-CSF R in some patients with severe congenital neutropenia. These mutations typically lead to a truncation in the cytoplasmic domain of the G-CSF R leading to maturation arrest of neutrophilic precursors in the bone marrow and neutropenia in peripheral blood. Binding of G-CSF to its receptor induces dimerization or oligomerization of the receptor activating cytoplasmic tyrosine kinases. Signal transduction from pathways that involve Janus tyrosine kinases/signal transducer and activator of transcription proteins (Jak1, Jak2, and Tyk2/STAT3 and STATG), src-related protein tyrosine kinases (Lyn and Syk), Ras/MAP kinase, and phosphatidylinositol have been reported to be activated upon G-CSF stimulation. Applications: Suitable for use in Neutralization Other applications not tested. Recommended Dilution: Neutralization: Measured by its ability to neutralize G‑CSF-induced proliferation in the NFS-60 mouse myeloid cell line.. The Neutralization Dose (ND50) is typically 0.015-0.075ug/mL in the presence of 0.15ng/ml recombinant mouse G‑CSF. Optimal dilutions to be determined by the researcher. Storage and Stability: Lyophilized and reconstituted products are stable for 12 months after receipt at -20°C. Reconstitute with sterile PBS. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
- Host:
- Rat
- Immunogen:
- Recombinant protein corresponding to Cys26-Asp626 from mouse G-CSF R, expressed in NS0 cells.
- Isotype:
- IgG2b
- Physical State:
- Supplied as a lyophilized powder in PBS, 5% trehalose. Reconstitute with 1ml sterile PBS.
- Purity:
- Purified by Protein G affinity chromatography from culture supernatant.. Endotoxin: ≤0.1EU/ug (LAL).
- Shipping Conditions:
- Blue Ice
- Specificity:
- Recognizes mouse G-CSF R. Does not react with recombinant human G-CSF R, GM-CSF R beta or recombinant mouse GM-CSF R alpha, M-CSF R.
- Source:
- mouse
- Storage Conditions:
- -20[o]C
- Supplier:
- United States Biological
- Type:
- Antibodies:Monoclonal Antibody
